Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases

被引:18
作者
Huo, Lanqing [1 ]
Wang, Dan [1 ]
Wang, Wenze [2 ]
Cao, Dongyan [1 ]
Yang, Jiaxin [1 ]
Wu, Ming [1 ]
Yang, Junjun [1 ]
Xiang, Yang [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
smooth muscle tumor; uncertain malignant potential; surgical procedure; recurrence; reproductive outcomes; LEIOMYOSARCOMAS; LEIOMYOMAS; EXPRESSION; VARIANTS; STUMP; P16; P53;
D O I
10.3389/fonc.2020.00647
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The term "uterine smooth muscle tumor of uncertain malignant potential" (STUMP) indicates a rare tumor that cannot be classified as a benign leiomyoma or malignant leiomyosarcoma. In this study, we assessed the clinical characteristics, fertility, and oncologic outcomes of patients diagnosed as STUMP in 14 years. In addition, we analyzed the risk factors for recurrence in patients with STUMP. Methods: Medical records of STUMP patients at Peking Union Medical College Hospital (PUMCH) between January 2005 and June 2019 were reviewed and analyzed. Disease-free survival, age of diagnosis, tumor size, surgical procedure, pathology and immunohistochemistry, clinical characteristics, recurrence rate, and reproductive outcomes in the follow-up period were assessed. Univariate and multivariate analyses were performed to determine the prognostic factors. Results: The median age was 42 years old (range: 21-63). Total hysterectomy with or without bilateral salpingo-oophorectomy was performed in 29/67 cases (43.3%), and myomectomy was performed in 38/67 cases (56.7%). Ten patients experienced recurrences, and all but two recurrences occurred within 5 years after the initial surgery. Only two of these recurrences were leiomyosarcoma. There were no deaths in themedian follow-up period of 48.4 (range 2.6-170.2) months. There were no remarkable differences in location of tumor between the myomectomy and hysterectomy groups, but the patients in the myomectomy group were younger than those in the hysterectomy group. In univariate and multivariate analysis, mitosis on pathology was the only independent risk factor for recurrence. Expression of Ki-67, p53, and p16 was significantly higher in patients with recurrence. Seven of the 35 patients who attempted to conceive had successful pregnancies. Conclusions: The prognosis of STUMP was favorable and tumors with more than 10 mitoses per 10 high power field should be monitored closely. The surgical procedure was not an independent risk factor of recurrence, and myomectomy may be an acceptable option for patients wishing to preserve fertility.
引用
收藏
页数:8
相关论文
共 21 条
  • [1] Bacanakgil Besim Haluk, 2017, World J Oncol, V8, P76, DOI 10.14740/wjon1031w
  • [2] The Clinicopathological Study of 21 Cases With Uterine Smooth Muscle Tumors of Uncertain Malignant Potential Centralized Review Can Purify the Diagnosis
    Basaran, Derman
    Usubutun, Alp
    Salman, Mehmet Coskun
    Narin, Mehmet Ali
    Boyraz, Gokhan
    Turkmen, Osman
    Kimyon, Gunsu Comert
    Karalok, Alper
    Bulbul, Dilek
    Turan, Taner
    Ozgul, Nejat
    Yuce, Kunter
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (02) : 233 - 240
  • [3] PROBLEMATIC UTERINE SMOOTH-MUSCLE NEOPLASMS - A CLINICOPATHOLOGICAL STUDY OF 213 CASES
    BELL, SW
    KEMPSON, RL
    HENDRICKSON, MR
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (06) : 535 - 558
  • [4] Cao HY, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019481
  • [5] Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors
    Chen, Longwen
    Yang, Bin
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2008, 27 (03) : 326 - 332
  • [6] Dall'Asta A, 2014, INT J CLIN EXP PATHO, V7, P8136
  • [7] Danska-Bidzinska A, 2012, GINEKOL POL, V83, P412
  • [8] Uterine fibroid management: from the present to the future
    Donnez, Jacques
    Dolmans, Marie-Madeleine
    [J]. HUMAN REPRODUCTION UPDATE, 2016, 22 (06) : 665 - 686
  • [9] Uterine smooth muscle tumors of unknown malignant potential: A challenging question
    Gadducci, Angiolo
    Zannoni, Gian Franco
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 (03) : 631 - 637
  • [10] Uterine smooth muscle tumor of uncertain malignant potential: A retrospective analysis
    Guntupalli, Saketh R.
    Ramirez, Pedro T.
    Anderson, Matthew L.
    Milam, Michael R.
    Bodurka, Diane C.
    Malpica, Anais
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 113 (03) : 324 - 326